Long-Term Effect of Intravitreal Ranibizumab Injection on Choroidal Neovascularization in Age-Related Macular Degeneration

2013 ◽  
Vol 54 (9) ◽  
pp. 1359 ◽  
Author(s):  
Hyo Ju Jang ◽  
Su Jeong Song ◽  
Jeong Hoon Bae
Keyword(s):  
Macular Degeneration ◽  
Choroidal Neovascularization ◽  
Term Effect ◽  
Age Related Macular Degeneration ◽  
Intravitreal Ranibizumab ◽  
Age Related ◽  
Long Term Effect

Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degeneration

2019 ◽  
Vol 257 (7) ◽  
pp. 1459-1466 ◽  
Author(s):  
Alicia Valverde-Megías ◽  
Aurora Ruiz-Calvo ◽  
Antonio Murciano-Cespedosa ◽  
Samuel Hernández-Ruiz ◽  
Jose María Martínez-de-la-Casa ◽  
...  
Keyword(s):  
Macular Degeneration ◽  
Nerve Fiber ◽  
Retinal Nerve Fiber Layer ◽  
Term Effect ◽  
Age Related Macular Degeneration ◽  
Intravitreal Ranibizumab ◽  
Fiber Layer ◽  
Age Related ◽  
Long Term Effect

Long-Term Effect of Laser Treatment for Dry Age-Related Macular Degeneration on Choroidal Hemodynamics

2006 ◽  
Vol 141 (5) ◽  
pp. 863-867 ◽  
Author(s):  
Mauricio Figueroa ◽  
Lisa S. Schocket ◽  
Joan DuPont ◽  
Tatyana I. Metelitsina ◽  
Juan E. Grunwald
Keyword(s):  
Macular Degeneration ◽  
Laser Treatment ◽  
Term Effect ◽  
Age Related Macular Degeneration ◽  
Age Related ◽  
Long Term Effect

scholarly journals Long-Term Effect of Anti-VEGF Agents on Intraocular Pressure in Age-Related Macular Degeneration

2016 ◽  
Vol 56 (1) ◽  
pp. 30-34 ◽  
Author(s):  
João Beato ◽  
Ana Catarina Pedrosa ◽  
João Pinheiro-Costa ◽  
Paulo Freitas-da-Costa ◽  
Manuel S. Falcão ◽  
...  
Keyword(s):  
Intraocular Pressure ◽  
Macular Degeneration ◽  
Term Effect ◽  
Age Related Macular Degeneration ◽  
Anti Vegf ◽  
Age Related ◽  
Long Term Effect

scholarly journals Long term intravitreal ranibizumab treatment for exsudative age-related macular degeneration

2013 ◽  
Vol 154 (45) ◽  
pp. 1790-1797 ◽  
Author(s):  
Regina Lukács ◽  
Miklós Resch ◽  
András Papp ◽  
Antal Szabó ◽  
Ágnes Borbándy ◽  
...  
Keyword(s):  
Macular Degeneration ◽  
Retinal Thickness ◽  
Age Related Macular Degeneration ◽  
Central Retinal Thickness ◽  
First Year ◽  
Intravitreal Ranibizumab ◽  
Age Related ◽  
Pro Re Nata ◽  
Ranibizumab Treatment

Introduction: The results of intravitreal ranibizumab treatment for exsudative age-related macular degeneration have been favourable until this time. Aim: To evaluate the two-year functional and anatomic results of intravitreal ranibizumab treatment. Method: 46 patients (age: 75±9.1 years) were included in a prospective single center study. Treatment regimen was the following: monthly 0.5 mg ranibizumab was administered in the first 3 months, and later as required (pro re nata). The change of best corrected visual acuity and central retinal thickness was followed. Results: The visus change at the end of the follow-up time was not statistically significant compared to baseline (p = 0.760) and the at the end of the first year (p = 0.154). Central retinal thickness decreased significantly compared to baseline (p = 0.000001), but the change was not statistically significant compared to the end of the first year (p = 0.875). Conclusions: Patients with neovascular macular degeneration treated with intravitreal ranibizumab using pro re nata regimen have stable visus for long term, and the exsudation could be reduced efficiently. Orv. Hetil., 154(45), 1790–1797.

Sign in / Sign up

Export Citation Format

Share Document